therapeutic action: improved quality of life

Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study

mycolabadmin

This study shows that when cancer patients use complementary treatments like mushroom supplements, vitamins, and probiotics alongside their cancer medications under doctor supervision, they experience fewer side effects and better quality of life. Almost 93% of patients had no side effects from these supplements, and many reported less fatigue and better overall wellness. The key finding is that patients should work with their medical team rather than self-prescribing these treatments to avoid dangerous interactions.

Read More »

Anhedonia: Current and future treatments

mycolabadmin

Anhedonia is the inability to feel pleasure from activities, which is a significant problem affecting many people with depression and other psychiatric conditions. This review examined many different treatments for anhedonia including medications, brain stimulation techniques, and psychological therapies. The research shows that newer medications like vortioxetine and ketamine work better for anhedonia than older antidepressants, and combining multiple approaches including therapy and lifestyle changes gives the best results.

Read More »

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

mycolabadmin

Researchers tested whether people with severe depression could take psilocybin (a compound from certain mushrooms) while staying on their antidepressant medications. In this study of 19 people, those who received psilocybin with psychological support while continuing their SSRI showed significant improvement in depression symptoms over three weeks, with response rates of 42%. Side effects were mostly mild and temporary, suggesting this approach may be safe and effective without requiring patients to stop their current antidepressants.

Read More »

Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report

mycolabadmin

A 54-year-old man with terminal throat cancer received a single dose of LSD (100 μg) as part of psychedelic-assisted therapy delivered at his home. The treatment helped him experience relief from existential distress and feelings of peace. Six months later, he was in better psychological health, more motivated to pursue meaningful activities, and had discontinued pain medications while maintaining stability. This case demonstrates that psychedelic therapy can be safely administered at home for patients with life-threatening illnesses seeking existential relief.

Read More »

En Bloc Bipolar Prostate Enucleation Using the Mushroom Technique with Early Apical Release: Short-Term Outcomes

mycolabadmin

This study describes a new surgical technique for treating enlarged prostates that cause urinary problems. Instead of using expensive tissue-removing machines, surgeons used a simpler method inspired by mushroom shapes to safely remove the enlarged prostate tissue. The results showed that patients experienced significant improvements in urinary flow and symptoms, with most side effects being temporary and manageable.

Read More »

Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon

mycolabadmin

Psilocybin, the active compound in certain mushrooms, shows promise as a treatment for depression and anxiety in cancer patients, particularly those nearing end of life. Oregon legalized supervised psilocybin therapy in 2020, making it the first U.S. state to do so. While clinical research shows the treatment can rapidly reduce depression and improve quality of life, the actual rollout has faced challenges including regulatory hurdles, lack of professional standards, and unequal geographic access.

Read More »
Scroll to Top